Advertisement

Intermittent Education and Audit and Feedback Reduce Inappropriate Prescribing of Oral Third-Generation Cephalosporins for Pediatric Upper Respiratory Tract Infections

Published:December 14, 2020DOI:https://doi.org/10.1016/j.jcjq.2020.12.003

      Objective

      In June 2017, leaders within a pediatric ambulatory care network in Houston approached the antimicrobial stewardship team at Texas Children's Hospital with concerns for high oral third-generation cephalosporin (oTGC) use in their clinics. An outpatient quality improvement (QI) team was formed. The specific aim was to reduce inappropriate oTGC prescribing at one clinic (“Clinic A”) by 15% in one year.

      Methods

      Following a benchmark analysis of oTGC use at Clinic A, Plan-Do-Study-Act (PDSA) cycles were designed and conducted over one year: one educational session, three individual audit and feedback sessions, and one group feedback session. The primary outcome was the percentage of oTGCs not aligning with American Academy of Pediatrics (AAP) guidelines for bacterial upper respiratory tract infections. Monthly oTGC prescribing at Clinic A was also compared to four control clinics.

      Results

      In June 2017, 72% (231/322) of oTGCs prescriptions at Clinic A did not align with AAP guidelines. The most common diagnosis was primary/nonrecurrent acute otitis media. Following interventions, the mean percentage inappropriate oTGCs decreased from 72% to 45% (absolute reduction 27%, p < 0.001), which was sustained the year following the last PDSA cycle (absolute reduction 26%, p < 0.001). Total monthly oTGC prescribing at Clinic A decreased over time, but not in four control clinics. Provider active participation in stewardship activities decreased over time.

      Conclusion

      Intermittent education and audit and feedback were associated with reduced oTGC misuse at Clinic A but not at four control clinics. Improvements were maintained despite decreased participation in stewardship activities, suggesting that perceptions of ongoing antibiotic audits can help sustain prescribing improvements.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Joint Commission Journal on Quality and Patient Safety
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Elligsen M.
        • et al.
        Prospective audit and feedback of antimicrobial stewardship in critical care: program implementation, experience, and challenges.
        Can J Hosp Pharm. 2012; 65: 31-36
        • Newland J.G.
        • et al.
        Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children's hospital.
        J Pediatric Infect Dis Soc. 2012; 1: 179-186
        • DiazGranados C.A.
        Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes.
        Am J Infect Control. 2012; 40: 526-529
        • Metjian T.A.
        • et al.
        Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital.
        Pediatr Infect Dis J. 2008; 27: 106-111
        • Elligsen M.
        • et al.
        Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis.
        Infect Control Hosp Epidemiol. 2012; 33: 354-361
        • Buising K.L.
        • et al.
        Electronic antibiotic stewardship—reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting.
        J Antimicrob Chemother. 2008; 62: 608-616
        • White Jr., A.C.
        • et al.
        Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.
        Clin Infect Dis. 1997; 25: 230-239
        • Society for Healthcare Epidemiology of America, Infectious Diseases Society of America
        • Pediatric Infectious Diseases Society
        Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).
        Infect Control Hosp Epidemiol. 2012; 33: 322-327
        • Suda K.J.
        • et al.
        A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009.
        J Antimicrob Chemother. 2013; 68: 715-718
        • Dellit T.H.
        • et al.
        Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.
        Clin Infect Dis. 2007 Jan 15; 44: 159-177
      1. The Joint Commission. Antimicrobial stewardship in ambulatory health care. R3 Report, Issue 23. Jun 20, 2019. Accessed Dec 19, 2020. https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_23_antimicrobial_stewardship_amb_6_14_19_final2.pdf.

        • Zetts R.M.
        • et al.
        Outpatient antibiotic use and the need for increased antibiotic stewardship efforts.
        Pediatrics. 2018; 141e20174124
        • Arnold S.R.
        • Straus S.E.
        Interventions to improve antibiotic prescribing practices in ambulatory care.
        Cochrane Database Syst Rev. 2005 Oct 19; CD003539
        • Drekonja D.M.
        • et al.
        Antimicrobial stewardship in outpatient settings: a systematic review.
        Infect Control Hosp Epidemiol. 2015; 36: 142-152
        • Gerber J.S.
        • et al.
        Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial.
        JAMA. 2013 Jun 12; 309: 2345-2352
        • Hersh A.L.
        • et al.
        Antibiotic prescribing in ambulatory pediatrics in the United States.
        Pediatrics. 2011; 128: 1053-1061
        • Fleming-Dutra K.E.
        • et al.
        Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011.
        JAMA. 2016 May 3; 315: 1864-1873
        • Hersh A.L.
        • et al.
        Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics.
        Pediatrics. 2013; 132: 1146-1154
        • Lieberthal A.S.
        • et al.
        The diagnosis and management of acute otitis media.
        Pediatrics. 2013; 131: e964-e999
        • Wald E.R.
        • et al.
        Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years.
        Pediatrics. 2013; 132: e262-e280
        • Harrison C.J.
        • et al.
        Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
        J Antimicrob Chemother. 2009; 63: 511-519
        • Parker S.
        • Mitchell M.
        • Child J.
        Cephem antibiotics: wise use today preserves cure for tomorrow.
        Pediatr Rev. 2013; 34: 510-523
        • Coco A.
        • et al.
        Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline.
        Pediatrics. 2010; 125: 214-220
        • Hedrick J.A.
        Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins.
        Expert Rev Anti Infect Ther. 2010; 8: 15-21
        • Sanchez G.V.
        • et al.
        Core Elements of Outpatient Antibiotic Stewardship.
        MMWR Recomm Rep. 2016 Nov 11; 65: 1-12
        • Langley G.L.
        • et al.
        The Improvement Guide: A Practical Approach to Enhancing Organizational Performance.
        2nd ed. Jossey-Bass, San Francisco2009
        • Song P.
        • Li W.
        • Zhou Q.
        An outpatient antibacterial stewardship intervention during the journey to JCI accreditation.
        BMC Pharmacol Toxicol. 2014 Feb 26; 15: 8
        • Meeker D.
        • et al.
        Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial.
        JAMA. 2016 Feb 9; 315: 562-570
      2. Jamovi. Home page. Accessed Dec 19, 2020. https://www.jamovi.org.

        • Hersh A.L.
        • et al.
        Frequency of first-line antibiotic selection among us ambulatory care visits for otitis media, sinusitis, and pharyngitis.
        JAMA Intern Med. 2016 Dec 1; 176: 1870-1872